Time in tight range in automated insulin delivery system users: Real-world data from children and adolescents with type 1 diabetes
- PMID: 39021339
- DOI: 10.1111/dom.15791
Time in tight range in automated insulin delivery system users: Real-world data from children and adolescents with type 1 diabetes
Keywords: CGM metrics; Medtronic Minimed™ 780G; Tandem t:Slim X2™ Control IQ; paediatrics; target.
References
REFERENCES
-
- Jendle J, Reznik Y. Use of insulin pumps and closed‐loop systems among people living with diabetes: a narrative review of clinical and cost‐effectiveness to enable access to technology and meet the needs of payers. Diabetes Obes Metab. 2023;25(Suppl 2):21‐32.
-
- Phillip M, Nimri R, Bergenstal RM, et al. Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. Endocr Rev. 2023;44(2):254‐280.
-
- Battelino T, Alexander CM, Amiel SA, et al. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 2023;11(1):42‐57.
-
- Akturk HK, Battelino T, Castañeda J, Arrieta A, van den Heuvel T, Cohen O. Future of time‐in‐range goals in the era of advanced hybrid closed‐loop automated insulin delivery systems. Diabetes Technol Ther. 2024;26(S3):102‐106.
-
- Libman I, Haynes A, Lyons S, et al. ISPAD clinical practice consensus guidelines 2022: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2022;23(8):1160‐1174.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials